1. Scher RK, Rich P, Pariser D, Elewski B. The epidemiology, etiology, and pathophysiology of onychomycosis. Semin Cutan Med Surg. 2013; 32:2 Suppl 1. S2–S4.
Article
2. Ameen M, Lear JT, Madan V, Mohd Mustapa MF, Richardson M. British Association of Dermatologists' guidelines for the management of onychomycosis 2014. Br J Dermatol. 2014; 171:937–958.
Article
3. Francuzik W, Fritz K, Salavastru C. Laser therapies for onychomycosis - critical evaluation of methods and effectiveness. J Eur Acad Dermatol Venereol. 2016; 30:936–942.
Article
4. Gupta AK, Paquet M. A retrospective chart review of the clinical efficacy of Nd:YAG 1064-nm laser for toenail onychomycosis. J Dermatolog Treat. 2015; 26:376–378.
Article
5. Kim TI, Shin MK, Jeong KH, Suh DH, Lee SJ, Oh IH, et al. A randomised comparative study of 1064 nm Neodymium-doped yttrium aluminium garnet (Nd:YAG) laser and topical antifungal treatment of onychomycosis. Mycoses. 2016; 59:803–810.
Article
6. Karsai S, Jäger M, Oesterhelt A, Weiss C, Schneider SW, Jünger M, et al. Treating onychomycosis with the short-pulsed 1064-nm-Nd:YAG laser: results of a prospective randomized controlled trial. J Eur Acad Dermatol Venereol. 2017; 31:175–180.
Article
7. Carney C, Tosti A, Daniel R, Scher R, Rich P, DeCoster J, et al. A new classification system for grading the severity of onychomycosis: Onychomycosis Severity Index. Arch Dermatol. 2011; 147:1277–1282.
Article
8. Shin MK, Kim TI, Kim WS, Park HK, Kim KS. Changes in nail keratin observed by Raman spectroscopy after Nd:YAG laser treatment. Microsc Res Tech. 2017; 80:338–343.
Article